In addition to being prevalent among DCM patients, RBM20 mutations rank first for the youngest mean age of heart transplantation and are correlated with advanced disease (Brauch et al., 2009; Kayvanpour et al., 2017) (Table 1). Here, RBM20 is linked to familial dilated cardiomyopathy.